AB0441 NAILFOLDCAPILLAROSCOPY and Candidate Biomarker Levels in Systemic Sclerosis- Associated Pulmonary Hypertension; Profiling of Non-Invasive Markers, a Cohort Study (original ) (raw )Screening for Pulmonary Hypertension in Systemic Sclerosis—A Primer for Cardio-Rheumatology Clinics
Carina Mihai
Diagnostics, 2021
View PDFchevron_right
An Evidence-Based Screening Algorithm for Pulmonary Arterial Hypertension in Systemic Sclerosis: The DETECT Study
Madelon Vonk
CHEST Journal, 2012
View PDFchevron_right
Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Carlos Cañas
European respiratory review : an official journal of the European Respiratory Society, 2011
View PDFchevron_right
Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up
Rogério Rufino
BMC Pulmonary Medicine, 2021
View PDFchevron_right
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival
Loïc Guillevin
Arthritis & Rheumatism, 2011
View PDFchevron_right
Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study
Roberto Badagliacca
Rheumatology, 2013
View PDFchevron_right
Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury
Raphaël Lemaire
2010
View PDFchevron_right
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort
Carina Mihai
Annals of the rheumatic diseases, 2017
View PDFchevron_right
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study
Vivien Hsu
Seminars in Arthritis and Rheumatism, 2014
View PDFchevron_right
OP0238 Immunosuppression with Targeted Dmards Reduces Morbidity and Mortality in Pre-Capillary Pulmonary Hypertension Associated with Systemic Sclerosis: A Eustar Analysis
Daniela Opris-Belinski
Annals of the Rheumatic Diseases, 2023
View PDFchevron_right
Survival and Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry
Richard Silver
Arthritis Care & Research, 2014
View PDFchevron_right
Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations
Lorenzo Beretta
Arthritis & Rheumatism, 2011
View PDFchevron_right
Pulmonary arterial hypertension associated with systemic sclerosis
Maurice Beghetti , Stephen Mathai
Expert Review of Respiratory Medicine, 2011
View PDFchevron_right
Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)
Rahul Argula
Therapeutics and Clinical Risk Management, 2019
View PDFchevron_right
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment
Carlo Gabriele Tocchetti
International Journal of Molecular Sciences
View PDFchevron_right
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis
Christophe Guignabert
Annals of the Rheumatic Diseases, 2022
View PDFchevron_right
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
Jérôme Le Pavec
PloS one, 2018
View PDFchevron_right
Systemic Sclerosis-associated Pulmonary Arterial Hypertension
Jérôme Le Pavec
American Journal of Respiratory and Critical Care Medicine, 2010
View PDFchevron_right
Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis
J. Seibold
Rheumatology, 2006
View PDFchevron_right
The role of nailfold capillaroscopy in monitoring lung involvement in systemic sclerosis
Violeta Claudia Bojinca
Romanian Journal of Rheumatology
View PDFchevron_right
Diagnosis and management of pulmonary hypertension in systemic sclerosis
Amit Patel , Ray Sawaqed
Current rheumatology reports, 2010
View PDFchevron_right
Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study
Molla Huq
BMC pulmonary medicine, 2016
View PDFchevron_right
Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis
Pieter E Postmus
Annals of the Rheumatic Diseases, 2009
View PDFchevron_right
Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies
Rosalia Torres
The Journal of Rheumatology, 2010
View PDFchevron_right
Proteomic Biomarkers for Survival in Systemic Sclerosis-associated Pulmonary Hypertension
Olivier Delezay
View PDFchevron_right
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
J. Seibold
Annals of the Rheumatic Diseases, 2013
View PDFchevron_right
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France
Pascal de Groote
Arthritis & Rheumatism, 2009
View PDFchevron_right
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
Maureen Rischmueller
Arthritis research & therapy, 2015
View PDFchevron_right
Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort
Dilia Giuggioli
2013
View PDFchevron_right
Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
Pascal de Groote
Arthritis & Rheumatism, 2005
View PDFchevron_right